Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Clinical forensic medicine in Eastern Denmark: Organisation and assessments

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. GWAS on longitudinal growth traits reveals different genetic factors influencing infant, child, and adult BMI

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Brain function and blood flow

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Myelodysplastic syndrome patient-derived xenografts: from no options to many

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. ERG Controls B Cell Development by Promoting Igh V-to-DJ Recombination

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

The key myeloid transcription factor (TF), CEBPA, is frequently mutated in acute myeloid leukemia (AML), but the direct molecular effects of this leukemic driver mutation remain elusive. To investigate CEBPA mutant AML, we performed microscale, in vivo chromatin immunoprecipitation sequencing and identified a set of aberrantly activated enhancers, exclusively occupied by the leukemia-associated CEBPA-p30 isoform. Comparing gene expression changes in human CEBPA mutant AML and the corresponding CebpaLp30 mouse model, we identified Nt5e, encoding CD73, as a cross-species AML gene with an upstream leukemic enhancer physically and functionally linked to the gene. Increased expression of CD73, mediated by the CEBPA-p30 isoform, sustained leukemic growth via the CD73/A2AR axis. Notably, targeting of this pathway enhanced survival of AML-transplanted mice. Our data thus indicate a first-in-class link between a cancer driver mutation in a TF and a druggable, direct transcriptional target.

OriginalsprogEngelsk
TidsskriftScientific American
Vol/bind5
Udgave nummer7
Sider (fra-til)eaaw4304
ISSN0036-8733
DOI
StatusUdgivet - 1 jan. 2019

ID: 57758371